CJC-1295 DAC

Long-acting GHRH receptor agonist

99.13% HPLC-MSBatch PH-4205Out of stock

$70per 2 mg vial

Vial strength

View purity report (COA)Ships in 1 business day

GHRH(1-29) analogue with substitutions that resist proteolysis and a reactive maleimide allowing covalent albumin binding. It prolongs GHRH receptor stimulation, increases pulsatile and basal GH output and raises IGF-1…

Specifications

Compound class: Long-acting GHRH receptor agonist
Sequence: Tetrasubstituted GHRH(1-29) analogue with C-terminal reactive group
Chain length: 29 aa core
Physical form: Lyophilized powder
Modifications: D-Ala2, Gln8, Ala15, Leu27 substitutions and DAC maleimide for albumin conjugation
Reported half-life: Estimated 5.8 to 8.1 days in healthy-adult study
Verified purity: 99.13% (HPLC-MS)
Evidence grade: E3 — Preliminary human data

Read the full monograph in the Peptide Atlas

Research use only. All products sold on this website are intended for laboratory research and in-vitro experimentation only. They are not drugs, foods, cosmetics, or medical devices, and are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this site should be construed as medical advice, dosing, or administration guidance. Purchasers must be qualified researchers or institutions and are solely responsible for lawful handling and use.